These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10956659)

  • 1. Interaction of the factor XIII activation peptide with alpha -thrombin. Crystal structure of its enzyme-substrate analog complex.
    Sadasivan C; Yee VC
    J Biol Chem; 2000 Nov; 275(47):36942-8. PubMed ID: 10956659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII.
    Yee VC; Pedersen LC; Bishop PD; Stenkamp RE; Teller DC
    Thromb Res; 1995 Jun; 78(5):389-97. PubMed ID: 7660355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation.
    Trumbo TA; Maurer MC
    J Biol Chem; 2000 Jul; 275(27):20627-31. PubMed ID: 10801785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII.
    Naski MC; Lorand L; Shafer JA
    Biochemistry; 1991 Jan; 30(4):934-41. PubMed ID: 1989686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41).
    Isetti G; Maurer MC
    J Pept Res; 2004 Mar; 63(3):241-52. PubMed ID: 15049836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V34I and V34A substitutions within the factor XIII activation peptide segment (28-41) affect interactions with the thrombin active site.
    Trumbo TA; Maurer MC
    Thromb Haemost; 2003 Apr; 89(4):647-53. PubMed ID: 12669118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of thrombin with fibrinogen. A structural basis for its specificity.
    Stubbs MT; Oschkinat H; Mayr I; Huber R; Angliker H; Stone SR; Bode W
    Eur J Biochem; 1992 May; 206(1):187-95. PubMed ID: 1587268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation. Competition for cofactor sites on thrombin determines its fate.
    Philippou H; Rance J; Myles T; Hall SW; Ariens RA; Grant PJ; Leung L; Lane DA
    J Biol Chem; 2003 Aug; 278(34):32020-6. PubMed ID: 12794066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of factor XIII activation peptide (28-41) V34L mutant bound to thrombin.
    Nair DG; Sunilkumar PN; Sadasivan C
    J Biomol Struct Dyn; 2008 Dec; 26(3):387-94. PubMed ID: 18808204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
    Isetti G; Maurer MC
    Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of fibrinogen-Aalpha peptide 1-23 (F8Y) bound to bovine thrombin explains why the mutation of Phe-8 to tyrosine strongly inhibits normal cleavage at Arg-16.
    Malkowski MG; Martin PD; Lord ST; Edwards BF
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):815-22. PubMed ID: 9307032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
    Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution NMR studies of fibrinogen-like peptides in solution: structure of a thrombin-bound peptide corresponding to residues 7-16 of the A alpha chain of human fibrinogen.
    Ni F; Meinwald YC; Vásquez M; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3094-105. PubMed ID: 2742827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
    Féthière J; Tsuda Y; Coulombe R; Konishi Y; Cygler M
    Protein Sci; 1996 Jun; 5(6):1174-83. PubMed ID: 8762149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the activation of bovine plasma factor XIII. Amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides.
    Nakamura S; Iwanaga S; Suzuki T
    J Biochem; 1975 Dec; 78(6):1247-66. PubMed ID: 1225922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Factor XIII β-Sandwich Residues Mediating Glutamine Substrate Binding and Activation Peptide Cleavage.
    Mohammed RDS; Piell KM; Maurer MC
    Thromb Haemost; 2024 May; 124(5):408-422. PubMed ID: 38040030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of thrombin-ecotin reveals conformational changes and extended interactions.
    Wang SX; Esmon CT; Fletterick RJ
    Biochemistry; 2001 Aug; 40(34):10038-46. PubMed ID: 11513582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
    Martin PD; Malkowski MG; DiMaio J; Konishi Y; Ni F; Edwards BF
    Biochemistry; 1996 Oct; 35(40):13030-9. PubMed ID: 8855938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate.
    Chang JY
    Eur J Biochem; 1985 Sep; 151(2):217-24. PubMed ID: 2863141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
    Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.